OTC · Medical - Devices

LexaGene Holdings Inc. (LXXGF) Stock

$0.08 +0.00% OTC: LXXGF Healthcare

LexaGene Holdings Inc. is a biotechnology firm dedicated to the innovation, development, and market release of systems designed for identifying pathogens.

Valuation

MetricValue
Price$0.08
Market Cap$11.34M
P/E Ratio-0.89
P/B Ratio1.89
P/S Ratio366.39
EPS (TTM)$-0.09
52-Week High$0.22
52-Week Low$0.05
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-183.33%
ROA-137.50%
ROCE-157.14%
Gross Margin-621.40%
Operating Margin—
Net Margin—
Debt/Equity0.20
Current Ratio7.12

Annual Financials (USD)

Metric20182019202020212022
Revenue$0$0$0$0$0
Operating Profit$-4.0M$-8.0M$-7.0M$-10.0M$-11.0M
Net Profit$-4.0M$-8.0M$-8.0M$-10.0M$-11.0M
EPS$-0.08$-0.13$-0.10$-0.10$-0.09
Op Margin———-16887.7%-14124.9%

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$4.0M$2.0M$6.0M$13.0M$8.0M
Total Liabilities$0$0$2.0M$2.0M$2.0M
Cash$3.0M$1.0M$3.0M$10.0M$5.0M
Borrowings$0$0$2.0M$2.0M$1.0M

Latest News

Gold Drops Amid Hawkish Monetary Policy Backdrop The Wall Street Journal · Jul 29, 2026 Gravita India Ltd (BOM:533282) Q1 2027 Earnings Call Highlights: Strong Revenue Growth Amidst ... GuruFocus.com · Jul 29, 2026 Coca-Cola Femsa SAB de CV (KOF) Q2 2026 Earnings Call Highlights: Strong Growth in South ... GuruFocus.com · Jul 29, 2026 Orange SA (ORANY) (H1 2026) Earnings Call Highlights: Record Revenue and Strategic Expansions GuruFocus.com · Jul 29, 2026 Macronix International Co Ltd (TPE:2337) Q2 2026 Earnings Call Highlights: Navigating Market ... GuruFocus.com · Jul 29, 2026

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$-4.0M$-6.0M$-5.0M$-9.0M$-10.0M
Investing Cash Flow$-1.0M$0$-1.0M$0$0
Financing Cash Flow$6.0M$4.0M$9.0M$15.0M$5.0M
Net Cash Flow$2.0M$-2.0M$3.0M$6.0M$-5.0M
Free Cash Flow$-4.0M$-6.0M$-6.0M$-9.0M$-10.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-2.40
FCF Yield-88.22%
Quick Ratio5.61
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATBPFAntibe Therapeutics Inc. $0.22 -0.19% -0.80 $11.43M 0.00%
AVEFFAvecho Biotechnology Limited $0.00 — -15.71 $13.35M 0.00%
CDXFFCloud DX Inc. $0.09 +12.50% -1.14 $9.75M 0.00%
CNPOFRIV Capital Inc. $0.08 +0.00% -0.15 $10.96M 0.00%
EIGRQEiger BioPharmaceuticals, Inc. $8.50 +6.25% -0.17 $12.59M 0.00%

About LexaGene Holdings Inc.

LexaGene Holdings Inc. is a biotechnology firm dedicated to the innovation, development, and market release of systems designed for identifying pathogens. Its core offering is MiQLab, an automated pathogen detection platform poised to revolutionize how pathogens are detected in diverse fields, including veterinary and human clinical diagnostics, food and water safety analysis, and other life science applications. This cutting-edge system can be deployed directly where samples are collected, providing exceptional user-friendliness, precise sensitivity, and a broad scope for pathogen identification. The company was established in 2007 and operates from its headquarters in Beverly, Massachusetts.

LexaGene Holdings Inc. is headquartered in US.

LexaGene Holdings Inc. (LXXGF) stock trades at $0.08 with a market capitalization of $11.34M. The stock is valued at a price-to-earnings (P/E) ratio of -0.89, price-to-book of 1.89, price-to-sales of 366.39. Over the past 52 weeks the stock has ranged between $0.05 and $0.22, and currently trades 63.6% below its 52-week high.

On profitability, LexaGene Holdings Inc. generates a return on equity (ROE) of -183.33%, return on capital employed of -157.14%.

Official website: www.lexagene.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides